The DOJ announced on August 7, 2012 that Pfizer H.C.P., a subsidiary of Pfizer Inc., has agreed to pay $15 million to resolve FCPA violations arising out of conduct in various countries in Europe and Asia.  The Pfizer subsidiary has also agreed to pay $26.3 million in disgorgement of profits and pre-judgment interest to settle SEC charges; Wyeth LLC, a company Pfizer bought three years ago, agreed to pay $18.9 million in disgorgement and pre-judgment interest.  Pfizer reported in a November 2011 SEC filing that it had reached an agreement in principle with the government, but the details were not announced until nine months later.